| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:12097665:878 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:12097665:878?format=raw |
LEADER: 00878cam a22002291 4500
001 4011771
005 20221027015526.0
008 820821s1953 xx 000 0 eng d
035 $a(OCoLC)ocm14681378
035 $9AJV9797HS
035 $a4011771
040 $aNLM$cNLM$dZCH
060 00 $aW6$bP3 v.6097
110 2 $aBurroughs Wellcome and Company.$0http://id.loc.gov/authorities/names/n80146293
245 12 $aA brief resume on malaria :$bwith a preliminary report and bibliography on the interesting new antimalarial 'Daraprim' (Pyrimethamine) from the Medical Dept. and the Wellcome Research Laboratories, Burroughs Wellcome & Co.
260 $aTuckahoe, N. Y.,$c1953.
300 $a22 leaves
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aCover title.
710 2 $aWellcome Research Laboratories, London.
852 00 $boff,hsl$hRC156$i.B94 1953